跳至主要内容
临床试验/NCT07571954
NCT07571954尚未招募不适用

Prospective, Single-arm, Multi-centre Study to Evaluate the Efficacy and Safety of the Instroke 5F Thromboaspiration Catheter in Patients With Acute Ischaemic Stroke.

iVascular S.L.U.7 个研究点 分布在 2 个国家目标入组 45 人开始时间: 2026年8月31日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
45
试验地点
7

研究概览

简要总结

Prospective, single-arm, multi-centre study to evaluate the efficacy and safety of the iNstroke 5F thromboaspiration catheter in patients with acute ischaemic stroke

详细描述

This clinical investigation has been designed to evaluate the efficacy and safety of the iNstroke 5F aspiration catheter for its use in the treatment of LVO, with a view to comparing this product with standard therapy or with other similar products in a future pivotal clinical investigation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subjects aged ≥ 18 years.
  • Subjects able to be treated (i.e., defined by groin puncture time) within 24 hours of symptom onset or last time seen well.
  • Occlusion in a large or proximal medium vessel (M1, proximal M2, A2 or P2) identified by magnetic resonance angiography (MRA) or computed tomography angiography (CTA).
  • Baseline NIHSS score ≥ 6 assessed before the procedure.
  • Pre-stroke mRS score ≤
  • Subjects with an ASPECTS score ≥
  • Informed consent obtained in accordance with the applicable country-specific regulations and as approved by the Ethics Committee (EC).
  • France-specific inclusion criteria: As applicable under French law, subjects affiliated with a health social security scheme or equivalent.

排除标准

  • Severe comorbidity and/or shortened life expectancy that will likely prevent improvement or follow up or that will render the procedure unlikely to benefit the patient.
  • Severe allergy to contrast media.
  • Women of child-bearing potential.
  • Subjects with intracranial atherosclerotic occlusive disease or extra- or intracranial dissection.
  • Medical history of thrombocytopenia (Platelets <100,000).
  • Subjects with tandem occlusions (evidence of complete occlusion, high-grade stenosis or arterial dissection in the extracranial or petrous segment of the internal carotid artery).
  • Subjects with occlusions in multiple vessels.
  • Subjects with cancer who have a life expectancy of less than 6 months.
  • Pre-existing neurological or psychiatric illness that could confound the neurological or functional assessments.
  • Severe sustained hypertension (systolic pressure >185 mm Hg or diastolic pressure >110 mm Hg). Note: If blood pressure can be successfully reduced and maintained at an acceptable level by administering the medication recommended by the ESO (European Stroke Organisation) in its guidelines (also IV infusion of antihypertensives), the subject may be included.
  • Known or suspected cerebral vasculitis.
  • Known renal insufficiency with creatinine ≥3 mg/dl or Glomerular Filtration Rate (GFR) <30 mL/min.
  • Current participation in an interventional drug or device study that may confound the results of this study.
  • Intracranial stenosis proximal to the occlusion.
  • France-specific exclusion criteria: As applicable under French law, breastfeeding women, persons deprived of their liberty by a judicial or administrative decision, or persons of legal age who are the subject of a legal protection measure.

研究者

发起方
iVascular S.L.U.
申办方类型
Industry
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验